Norepinephrine
Norepinephrine (noradrenaline) is the primary signalling neurotransmitter of the autonomic sympathetic nervous system. This page covers the sodium-dependent noradrenaline transporter encoded by SLC6A2, also known as NET, NET1, NAT1 or SLC6A5, which clears norepinephrine from the synaptic cleft. Browse Assay Genie's current range of Norepinephrine research reagents below, or read on for the biology behind the target.
Norepinephrine is the primary signalling neurotransmitter in the autonomic sympathetic nervous system. Its action at the synapse is ended by the sodium-dependent noradrenaline transporter, which mediates sodium- and chloride-dependent transport of norepinephrine. By driving re-uptake and clearance from the synaptic cleft, the transporter plays a central role in norepinephrine inactivation and homeostasis. It can also mediate sodium- and chloride-dependent transport of dopamine.
The SLC6A2 gene encodes a member of the sodium:neurotransmitter symporter (SNF) family, in the SLC6A2 subfamily of the wider solute carrier family 6. The protein is a multi-pass membrane protein. UniProt places it at the cell membrane, in axons and in synaptosomes, consistent with its role in returning norepinephrine to presynaptic nerve terminals. Researchers studying this system may look for the norepinephrine transporter with an antibody or ELISA kit, or measure norepinephrine itself as a readout of noradrenergic activity. The mouse ortholog is Slc6a2, and alternatively spliced transcript variants encoding different isoforms have been identified for the human gene.
The gene has appeared in the literature under several names, including NET, NET1, NAT1 and SLC6A5, and earlier HGNC names described it as a neurotransmitter transporter for noradrenalin. Mutations in the SLC6A2 gene cause orthostatic intolerance, a syndrome characterised by lightheadedness, fatigue, altered mentation and syncope. This link ties transporter function directly to the regulation of norepinephrine homeostasis.
The transporter clears norepinephrine from the synaptic cleft, so it is central to studies of how signalling by this neurotransmitter is terminated.
Norepinephrine is the primary signalling neurotransmitter of the autonomic sympathetic nervous system, and its re-uptake helps maintain homeostasis.
Mutations in SLC6A2 cause orthostatic intolerance, a syndrome of lightheadedness, fatigue, altered mentation and syncope.
As an SLC6 sodium:neurotransmitter symporter, it is a model for sodium- and chloride-dependent transport of monoamines, including dopamine.
It mediates sodium- and chloride-dependent transport of norepinephrine, returning it from the synaptic cleft into presynaptic nerve terminals. This re-uptake and clearance inactivates the neurotransmitter and supports norepinephrine homeostasis. It can also transport dopamine in a sodium- and chloride-dependent manner.
SLC6A2 is also called NET, NET1, NAT1 and SLC6A5, and UniProt names the protein sodium-dependent noradrenaline transporter. Earlier HGNC names referred to it as a neurotransmitter transporter for noradrenalin. Alternatively spliced transcript variants encode different isoforms.
Mutations in the SLC6A2 gene cause orthostatic intolerance, with lightheadedness, fatigue, altered mentation and syncope. A mouse ortholog, Slc6a2, exists; check the datasheet of any product for its validated reactivity.
Other solute carriers, including vesicular monoamine and neurotransmitter transporters, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P23975; product specifications from Assay Genie datasheets.